Literature DB >> 19293632

Tie2 is tied at the cell-cell contacts and to extracellular matrix by angiopoietin-1.

Shigetomo Fukuhara, Keisuke Sako, Kazuomi Noda, Kaori Nagao, Koichi Miura, Naoki Mochizuki.   

Abstract

Angiopoietin-1 (Ang1) binds to and activates Tie2 receptor tyrosine kinase. Ang1-Tie2 signal has been proposed to exhibit two opposite roles in the controlling blood vessels. One is vascular stabilization and the other is vascular angiogenesis. There has been no answer to the question as to how Tie2 induces two opposite responses to the same ligand. Our group and Dr. Alitalos group have demonstrated that trans-associated Tie2 at cell-cell contacts and extracellular matrix (ECM)-anchored Tie2 play distinct roles in the endothelial cells. The complex formation depends on the presence or absence of cell-cell adhesion. Here, we review how Ang1-Tie2 signal regulates vascular maintenance and angiogenesis. We further point to the unanswered questions that must be clarified to extend our knowledge of vascular biology and to progress basic knowledge to the treatment of the diseases in which Ang1-Tie2-mediated signal is central.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293632      PMCID: PMC2679245          DOI: 10.3858/emm.2009.41.3.016

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  61 in total

1.  Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues.

Authors:  A L Wong; Z A Haroon; S Werner; M W Dewhirst; C S Greenberg; K G Peters
Journal:  Circ Res       Date:  1997-10       Impact factor: 17.367

2.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

Authors:  P C Maisonpierre; C Suri; P F Jones; S Bartunkova; S J Wiegand; C Radziejewski; D Compton; J McClain; T H Aldrich; N Papadopoulos; T J Daly; S Davis; T N Sato; G D Yancopoulos
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

3.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.

Authors:  T N Sato; Y Tozawa; U Deutsch; K Wolburg-Buchholz; Y Fujiwara; M Gendron-Maguire; T Gridley; H Wolburg; W Risau; Y Qin
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

4.  Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

Authors:  C Suri; P F Jones; S Patan; S Bartunkova; P C Maisonpierre; S Davis; T N Sato; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

5.  The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies.

Authors:  Ulrike Fiedler; Marion Scharpfenecker; Stefanie Koidl; Anja Hegen; Verena Grunow; Jarno M Schmidt; Wilhelm Kriz; Gavin Thurston; Hellmut G Augustin
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

6.  Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts.

Authors:  Pipsa Saharinen; Lauri Eklund; Juho Miettinen; Riikka Wirkkala; Andrey Anisimov; Mark Winderlich; Astrid Nottebaum; Dietmar Vestweber; Urban Deutsch; Gou Young Koh; Bjorn R Olsen; Kari Alitalo
Journal:  Nat Cell Biol       Date:  2008-04-20       Impact factor: 28.824

7.  Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells.

Authors:  M Hashiyama; A Iwama; K Ohshiro; K Kurozumi; K Yasunaga; Y Shimizu; Y Masuho; I Matsuda; N Yamaguchi; T Suda
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

8.  The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells.

Authors:  P Batard; P Sansilvestri; C Scheinecker; W Knapp; N Debili; W Vainchenker; H J Bühring; M N Monier; E Kukk; J Partanen; M T Matikainen; R Alitalo; J Hatzfeld; K Alitalo
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

9.  Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2.

Authors:  B Witzenbichler; P C Maisonpierre; P Jones; G D Yancopoulos; J M Isner
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

10.  Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis.

Authors:  B P Eliceiri; R Klemke; S Strömblad; D A Cheresh
Journal:  J Cell Biol       Date:  1998-03-09       Impact factor: 10.539

View more
  30 in total

1.  Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.

Authors:  Tomokazu Souma; Stuart W Tompson; Benjamin R Thomson; Owen M Siggs; Krishnakumar Kizhatil; Shinji Yamaguchi; Liang Feng; Vachiranee Limviphuvadh; Kristina N Whisenhunt; Sebastian Maurer-Stroh; Tammy L Yanovitch; Luba Kalaydjieva; Dimitar N Azmanov; Simone Finzi; Lucia Mauri; Shahrbanou Javadiyan; Emmanuelle Souzeau; Tiger Zhou; Alex W Hewitt; Bethany Kloss; Kathryn P Burdon; David A Mackey; Keri F Allen; Jonathan B Ruddle; Sing-Hui Lim; Steve Rozen; Khanh-Nhat Tran-Viet; Xiaorong Liu; Simon John; Janey L Wiggs; Francesca Pasutto; Jamie E Craig; Jing Jin; Susan E Quaggin; Terri L Young
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

Review 2.  Stem Cell Sources and Graft Material for Vascular Tissue Engineering.

Authors:  Dorothee Hielscher; Constanze Kaebisch; Benedikt Julius Valentin Braun; Kevin Gray; Edda Tobiasch
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

3.  Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study.

Authors:  Carlos Iribarren; Bruce H Phelps; Jeanne A Darbinian; Edward R McCluskey; Charles P Quesenberry; Evangelos Hytopoulos; Joseph H Vogelman; Norman Orentreich
Journal:  BMC Cardiovasc Disord       Date:  2011-06-14       Impact factor: 2.298

4.  Novel genetic approach for in vivo vascular imaging in mice.

Authors:  Benjamin B Bartelle; César A Berríos-Otero; Joe J Rodriguez; Anne E Friedland; Orlando Aristizábal; Daniel H Turnbull
Journal:  Circ Res       Date:  2012-02-28       Impact factor: 17.367

5.  Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.

Authors:  Dominique Thabut; Chittaranjan Routray; Gwen Lomberk; Uday Shergill; Kevin Glaser; Robert Huebert; Leena Patel; Tetyana Masyuk; Boris Blechacz; Andrew Vercnocke; Erik Ritman; Richard Ehman; Raul Urrutia; Vijay Shah
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

6.  Efficacy of Tie2 receptor antagonism in angiosarcoma.

Authors:  Jason R Hasenstein; Kelsey Kasmerchak; Darya Buehler; Gholam Reza Hafez; Kevin Cleary; John S Moody; Kevin R Kozak
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

7.  EphA4/Tie2 crosstalk regulates leptomeningeal collateral remodeling following ischemic stroke.

Authors:  Benjamin Okyere; William A Mills; Xia Wang; Michael Chen; Jiang Chen; Amanda Hazy; Yun Qian; John B Matson; Michelle H Theus
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 8.  Controlled protein delivery in the generation of microvascular networks.

Authors:  Jillian W Andrejecsk; William G Chang; Jordan S Pober; W Mark Saltzman
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

9.  Angiopoietin-1 facilitates recovery of hematopoiesis in radiated mice.

Authors:  Lan Sun; Huaibao Zhang; Laixi Bi; Yi-Fen Shi; Chongyun Xing; Liyuan Tang; Songfu Jiang; Kang Yu
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

10.  Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alpha- and beta-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells.

Authors:  Kazuomi Noda; Jianghui Zhang; Shigetomo Fukuhara; Satoshi Kunimoto; Michihiro Yoshimura; Naoki Mochizuki
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.